Quality Innovations And Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 15-05-2024
- Paid Up Capital ₹ 5.70 M
as on 15-05-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.46 M
as on 15-05-2024
- Satisfied Charges ₹ 1.50 M
as on 15-05-2024
- Revenue -5.21%
(FY 2021)
- Profit 21.17%
(FY 2021)
- Ebitda 11.58%
(FY 2021)
- Net Worth 17.88%
(FY 2021)
- Total Assets 19.45%
(FY 2021)
About Quality Innovations And Pharmaceuticals India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 5.70 M.
The company currently has active open charges totaling ₹7.46 M. The company has closed loans amounting to ₹1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kuttikat Unni and Sunila Unni serve as directors at the Company.
- CIN/LLPIN
U70100KL2004PTC017067
- Company No.
017067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Quality Innovations And Pharmaceuticals India Private Limited offer?
Quality Innovations And Pharmaceuticals India Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Quality Innovations And Pharmaceuticals India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuttikat Unni  | Managing Director | 26-Apr-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunila Unni | Whole-Time Director | 26-Apr-2004 | Current |
Financial Performance of Quality Innovations And Pharmaceuticals India.
Quality Innovations And Pharmaceuticals India Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 5.21% decrease. The company also saw a substantial improvement in profitability, with a 21.17% increase in profit. The company's net worth Soared by an impressive increase of 17.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quality Innovations And Pharmaceuticals India?
In 2021, Quality Innovations And Pharmaceuticals India had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Jul 2021 | ₹0.66 M | Open |
Hdfc Bank Limited Creation Date: 26 Jul 2019 | ₹3.80 M | Open |
State Bank Of India Creation Date: 09 May 2007 | ₹3.00 M | Open |
How Many Employees Work at Quality Innovations And Pharmaceuticals India?
Unlock and access historical data on people associated with Quality Innovations And Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quality Innovations And Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quality Innovations And Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
